Establishing robust governance of clinical artificial intelligence software – Why radiologists should lead

The longstanding research and development of artificial intelligence (AI) within the field of Diagnostic Radiology and the larger medical universe has begun to translate into clinically useful tools. As of this publication, there are over 500 AI based radiology applications approved by the Food and Drug Administration (FDA) for commercial sale in the United States.1,2 Additional AI based non-clinical applications are marketed to improve workflow, patient follow-up, and other noninterpretable or nonpatient-facing tasks.
Source: Clinical Imaging - Category: Radiology Authors: Tags: Editorial Source Type: research